TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY
NOVEMBER EDITION
|
|
|
|
Fran DeGrazio summarizes and comments on key clarifications and recommendations that emerged in a Drug Delivery Live! online event on the FDA's draft guidance on Essential Drug Delivery Outputs (EDDOs), which she moderated.
|
|
|
|
The CEO and CMO of emergency medicine company Crossject discuss how advances in needle-free autoinjectors can enable nearly immediate emergency treatment of an epileptic seizure or other sudden attack.
|
|
|
|
This article concludes the author's series on bacterial endotoxin testing. It discusses best practices for the labeled lysate sensitivity test, non-interfering dilution determination, and more.
|
|
|
|
In this episode of Supplier Horizons, Gabe Meister and Tony Duong from biopharmaceutical research and development company Battelle discuss the promise of polymer nanoparticles as delivery vehicles for treating rare diseases with in vivo gene therapies.
|
|
|
|
2024 has seen some promising advances in drug delivery technology. Strategic pharma/biotech companies may wish to seize these opportunities for their drug candidates in 2025.
|
|
|
|